Business Context and Reporting Period
This Form 6-K filing by MediWound Ltd. covers the month of June 2016. The report documents the results of the Company's annual general meeting of shareholders held on June 9, 2016.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting and does not contain financial statements.
Material Changes
No material financial changes are reported in this filing. The document focuses on the procedural outcome of the annual shareholder meeting.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding future performance in this filing. The report confirms that three proposals described in a prior proxy statement were approved by the shareholders. As of the record date (May 11, 2016), 21,850,300 ordinary shares were issued and outstanding. At the meeting, 14,237,413 shares (65.15%) were present in person or by proxy, establishing a quorum.
Important Facts for Investors to Verify
- Verify the specific details of the three approved proposals by reviewing the proxy statement filed on May 4, 2016 (Exhibit 99.1).
- Confirm the total number of outstanding shares (21,850,300) as of the May 11, 2016 record date.
- Note that this filing is incorporated by reference into Registration Statements on Form S-8 (filed April 28, 2014, and March 24, 2016) and Form F-3 (filed January 25, 2016).